Advertisement

Medical Treatment of Heart Failure: Ignore the Ejection Fraction and Treat All?

      The left ventricular ejection fraction (LVEF), the most widely used index of LV function, has an essential role in defining heart failure (HF) phenotypes and guiding treatment of chronic HF.
      • Maddox TM
      • Januzzi JL
      • Allen LA
      • Breathett K
      • Butler J
      • Davis LL
      • et al.
      2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Maddox TM
        • Januzzi JL
        • Allen LA
        • Breathett K
        • Butler J
        • Davis LL
        • et al.
        2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee.
        J Am Coll Cardiol. 2021; 77: 772-810
        • Triposkiadis F
        • Butler J
        • Abboud FM
        • Armstrong PW
        • Adamopoulos S
        • Atherton JJ
        • et al.
        The continuous heart failure spectrum: moving beyond an ejection fraction classification.
        Eur Heart J. 2019; 40: 2155-2163
        • Wehner GJ
        • Jing L
        • Haggerty CM
        • Suever JD
        • Leader JB
        • Hartzel DN
        • et al.
        Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?.
        Eur Heart J. 2020; 41: 1249-1257
        • Triposkiadis F
        • Giamouzis G
        • Boudoulas KD
        • Karagiannis G
        • Skoularigis J
        • Boudoulas H
        • et al.
        Left ventricular geometry as a major determinant of left ventricular ejection fraction: physiological considerations and clinical implications.
        Eur J Heart Fail. 2018; 20: 436-444
        • Anand V
        • Kane GC
        • Scott CG
        • Pislaru SV
        • Adigun RO
        • McCully RB
        • et al.
        Prognostic value of peak stress cardiac power in patients with normal ejection fraction undergoing exercise stress echocardiography.
        Eur Heart J. 2021; 42: 776-785
        • Badrov MB
        • Mak S
        • Floras JS.
        Cardiovascular autonomic disturbances in heart failure with preserved ejection fraction.
        Can J Cardiol. 2020 Dec 10; ([Epub ahead of print])
        • Solomon SD
        • Vaduganathan M
        • LC B
        • Packer M
        • Zile M
        • Swedberg K
        • et al.
        Sacubitril/valsartan across the spectrum of ejection fraction in heart failure.
        Circulation. 2020; 141: 352-361
        • Butler J
        • Usman MS
        • Khan MS
        • Greene SJ
        • Friede T
        • Vaduganathan M
        • et al.
        Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis.
        ESC Heart Fail. 2020; 7: 3298-3309